Story perspectives
Lenacapavir to Cost $40, Averting 4 Million HIV Deaths
9/27/2025
1 of 2
Prince Harry Warns
- Lenacapavir will cost $40 a year in 120 low- and middle-income countries starting in 2027.
- Unitaid and the Gates Foundation, with Indian firms, will produce generics.
- Lenacapavir marketed as Yeztugo reduces HIV transmission by over 99.9%.
- UNAIDS says U.S. funding reductions threaten global HIV response.
- Prince Harry warns cuts could cause 4 million deaths and 6 million infections in four years.
1 / 2
